OVERVIEW

The interventional cardiology devices market size is expected to surpass USD 21.40 billion by 2026 on account of COVID-19, growing at a CAGR of 8.9 percent over the forecast period. Globally, the outbreak of COVID-19 has impacted every aspect of the medical device industry, including the marketplace for interventional cardiology devices. within the past six months, the amount of patient visits to hospitals has reduced significantly, despite the very fact that emergency and OPD services are available in cardiology departments. Nationwide lockdowns and social distancing measures have reduced patient visits significantly. This has further reduced the sales of interventional cardiology products. Many of the leading players within the interventional cardiology devices market, like Boston Scientific, Medtronic, and Abbott, have registered a decline in sales.

TABLE OF CONTENT

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global Interventional Cardiology Devices Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global Interventional Cardiology Devices Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global Interventional Cardiology Devices Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global Interventional Cardiology Devices Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Opportunities
    • 6.2.3 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global Interventional Cardiology Devices Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global Interventional Cardiology Devices Market ? By Type (Market Size ? & million/billion)
  • 8.1 Angioplasty Balloons
  • 8.2 Angioplasty Stents
  • 8.3 Catheters
  • 8.4 Hemodynamic Flow Alteration Devices
  • 8.5 Others

• 9 Global Interventional Cardiology Devices Market - By Delivery Model
  • 9.1 Subscription
  • 9.2 Ownership

• 10 Global Interventional Cardiology Devices Market - By Function
  • 10.1 Clinical Functionality
  • 10.2 Administrative Functionality
  • 10.3 Financial Functionality

• 11 Global Interventional Cardiology Devices Market - By End-User
  • 11.1 Providers
    • 11.1.1 Community Clinics
    • 11.1.2 Hospitals
    • 11.1.3 Private Practices
  • 11.2 Payers
  • 11.3 Patients

• 12 Global Interventional Cardiology Devices Market ? By Geography (Market Size ? &

• • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 U.K
    • 12.3.2 Germany
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia-Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 South Korea
    • 12.4.5 Rest of APAC
  • 12.5 Rest of the World
    • 12.5.1 South America
    • 12.5.2 Middle East
    • 12.5.3 Africa

• 13 Global Interventional Cardiology Devices Market ? Entropy
  • 13.1 New product launches
  • 13.2 M&A's, collaborations, JVs and partnerships

• 14 Global Interventional Cardiology Devices Market Company Profile (Key Players)
  • 14.1 Market Share, Company Revenue, Products, M&A, Developments
  • 14.2 Medtronic
  • 14.3 Boston Scientific
  • 14.4 Abbott
  • 14.5 C. R. Bard
  • 14.6 Cordis
  • 14.7 Biotronik
  • 14.8 Ivascular
  • 14.9 Terumo
  • 14.10 B. Braun
  • 14.11 Biosensors
  • 14.12 Company 11 & more

• 15 Global Interventional Cardiology Devices Market - Appendix
  • 15.1 Sources
  • 15.2 Abbreviations